First among South Korea’s clinical trial sample analysis institutions, SK bioscience implements a La...

-Ana Brnabi?, Prime Minister of Serbia visited the SK bioscience headquarters.-SK bioscience signed ...

-SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collabora...

-SKYCellflu, the world’s first cell culture-based influenza vaccine obtaining WHO’s PQ, will be deli...

-SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation an...

SK bioscience donated to support the local community where L House, SK bioscience’s vaccine manufact...

SK bioscience identified 11 top-priority issues by adopting Double Materiality Assessment. Company e...

-Jaeyong Ahn, the CEO of SK bioscience, virtually joined the WHO workshop with representatives of gl...

SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response...

-The 21-valent pneumococcal conjugate vaccine candidate, GBP410 (also known as SP0202), demonstrates...

SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the P...

- In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 ...